Skip to main content

Aprea Therapeutics, Inc.

APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781983

No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.

Holders of 5% or more of APRE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aprea Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of APRE
HolderLatest formStakeChangeFirst filedLatest filingFiling
Soleus Private Equity Fund III, L.P.13G9.99%1.27M sharesNewApr 1, 20261 filingApr 1, 2026SEC
Vestal Point Capital, LP13G9.90%22.7M sharesNewMay 15, 20261 filingMay 15, 2026SEC
Squadron Capital Management LLC13G9.90%1.27M sharesNewApr 7, 20261 filingApr 7, 2026SEC
Hirschman Orin13G/A9.90%1.19M shares0.00 ppfrom 9.90%Mar 3, 20235 filingsApr 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

35 Schedule 13D and 13G filings on Aprea Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on APRE
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20262:27 PM ETLytton Laurence W13G/A3.20%390.8K shares−6.70 ppfrom 9.90%Below 5%Jun 30, 2026SEC
May 15, 20265:00 PM ETVestal Point Capital, LPand 1 other13G9.90%22.7M sharesNewMar 31, 2026SEC
Apr 27, 20268:09 AM ETHirschman Orinand 1 other13G/A9.90%1.19M shares0.00 ppfrom 9.90%Mar 31, 2026SEC
Apr 7, 20264:26 PM ETSquadron Capital Management LLCand 3 others13G9.90%1.27M sharesNewMar 30, 2026SEC
Apr 1, 20265:00 PM ETSoleus Private Equity Fund III, L.P.and 8 others13G9.99%1.27M sharesNewApr 1, 2026SEC
Feb 13, 20265:02 PM ETNantahala Capital Management, LLCand 2 others13G/A4.50%411.5K shares−2.80 ppfrom 7.30%Below 5%Dec 31, 2025SEC
Jan 28, 20262:02 PM ETHirschman Orinand 1 other13G/A9.90%651.7K shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Nov 17, 20257:16 PM ETLytton Laurence W13G9.90%681.8K sharesNewNov 13, 2025SEC
Nov 12, 20258:00 AM ETSio Capital Management, LLC13G/A1.93%112.2K shares−3.12 ppfrom 5.05%Below 5%Sep 30, 2025SEC
Aug 13, 20252:00 PM ETSio Capital Management, LLC13G/A5.05%279.4K shares+0.01 ppfrom 5.04%Jun 30, 2025SEC
May 14, 20254:04 PM ETStonepine Capital Management, LLCand 3 others13G/A4.30%239.4K shares−0.80 ppfrom 5.10%Below 5%Mar 31, 2025SEC
Apr 8, 20253:14 PM ETSio Capital Management, LLC13G/A5.04%276.6K shares−0.05 ppfrom 5.09%Mar 31, 2025SEC
Feb 13, 202512:15 PM ETStonepine Capital Management, LLCand 3 others13G/A5.10%286.4K shares–Dec 31, 2024SEC
Feb 10, 202512:56 PM ETSio Capital Management, LLC13G/A5.09%276.6K shares–Dec 31, 2024SEC
Feb 10, 20258:36 AM ETHirschman Orinand 1 other13G/A9.90%539.3K shares–Dec 31, 2024SEC
Nov 14, 20244:53 PM ETNantahala Capital Management, LLCand 2 others13G7.30%411.5K sharesNewSep 30, 2024SEC
Oct 10, 2024Stonepine Capital Management, LLC13GOld format–New–SEC
Feb 14, 2024Sio Capital Management, LLC13GOld format–New–SEC
Feb 7, 2024Hirschman Orin13G/AOld format–––SEC
Mar 3, 2023Hirschman Orin13GOld format–New–SEC
Nov 15, 2022HealthCap VII, L.P.13D/AOld format–––SEC
Jun 30, 2022HealthCap VII, L.P.13D/AOld format–––SEC
Feb 14, 2022Redmile Group, LLC13G/AOld format–––SEC
Feb 11, 2022Versant Ventures V, LLC13G/AOld format–––SEC
Oct 15, 2021HealthCap VII, L.P.13D/AOld format–––SEC
Oct 12, 2021Morgan Stanley13G/AOld format–––SEC
Mar 24, 2021Morgan Stanley13GOld format–New–SEC
Feb 16, 2021Versant Ventures V, LLC13G/AOld format–––SEC
Feb 16, 20215AM Ventures IV, L.P.13D/AOld format–––SEC
Feb 16, 2021Redmile Group, LLC13G/AOld format–––SEC
Feb 16, 2021KDev Investments AB13G/AOld format–––SEC
Feb 12, 2021Sectoral Asset Management Inc13G/AOld format–––SEC
Feb 11, 2021Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2021FMR LLC13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Aprea Therapeutics, Inc. shares.

No Form 144 notices for Aprea Therapeutics, Inc. are on file.